Melissa Johnson
Clinical Nurse Specialist · Murray, KYNPI 1104230598
Payments from drug & device makers
Across 119 payments — averaging $16.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$431
- Novartis$165
- Novo Nordisk$159
- Johnson & Johnson$148
- Amgen$130
- Lilly USA, LLC$109
- plus $779 from 22 others
What the payments were for
- Food & beverage$1,920100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
Too few clinical nurse specialist providers in Kentuckyto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 70 | $96,223 |
| EliquisApixaban | 48 | $51,295 |
| JardianceEmpagliflozin | 46 | $33,506 |
| MounjaroTirzepatide | 30 | $28,812 |
| EntrestoSacubitril/Valsartan | 29 | $25,144 |
| XareltoRivaroxaban | 26 | $21,679 |
| LinzessLinaclotide | 30 | $21,007 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 36 | $19,018 |
| Spiriva RespimatTiotropium Bromide | 27 | $17,665 |
| TrulicityDulaglutide | 16 | $17,518 |
| JanuviaSitagliptin Phosphate | 21 | $14,669 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 22 | $13,766 |
| Bevespi AerosphereGlycopyrrolate/Formoterol Fum | 26 | $13,240 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 11 | $9,321 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 277 | $7,451 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $159 | $96,22370 claims |
| Boehringer IngelheimJardiance, Stiolto Respimat, Spiriva Respimat | $98 | $70,189109 claims |
| PfizerEliquis | $49 | $51,29548 claims |
| Lilly USA, LLCMounjaro, Trulicity | $109 | $46,33046 claims |
| NovartisEntresto | $165 | $25,14429 claims |
| Johnson & JohnsonXarelto | $148 | $21,67926 claims |
| AbbVieLinzess | $431 | $21,00730 claims |
| MerckJanuvia, Dulera | $44 | $19,24534 claims |
| GSKTrelegy Ellipta | $42 | $13,76622 claims |
| AstraZenecaBevespi Aerosphere | $24 | $13,24026 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few clinical nurse specialist providers in Kentuckyon file to place this against a meaningful peer group, so we don't.
Other clinical nurse specialist in Murray
- Regina MarcinekLexington$1K
- Rhonda CaseyLouisville$924
- Elizabeth Archer-NandaLouisville$583
- Karen MulhollandLexington$554
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.